Optical Brighteners
The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More
Global Ophthalmology Drugs & Devices Market Research Report 2024
1 Ophthalmology Drugs & Devices Market Overview
1.1 Product Overview and Scope of Ophthalmology Drugs & Devices
1.2 Ophthalmology Drugs & Devices Segment by Type
1.2.1 Global Ophthalmology Drugs & Devices Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Diagnostic and Monitoring Devices
1.2.3 Surgical Devices
1.2.4 Vision Care Product
1.2.5 Ophthalmology Drugs
1.3 Ophthalmology Drugs & Devices Segment by Application
1.3.1 Global Ophthalmology Drugs & Devices Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Specialty Clinics
1.3.4 Ambulatory Surgical Centers (ASCs)
1.4 Global Ophthalmology Drugs & Devices Market Size Estimates and Forecasts
1.4.1 Global Ophthalmology Drugs & Devices Revenue 2017-2028
1.4.2 Global Ophthalmology Drugs & Devices Sales 2017-2028
1.4.3 Ophthalmology Drugs & Devices Market Size by Region: 2017 Versus 2021 Versus 2028
2 Ophthalmology Drugs & Devices Market Competition by Manufacturers
2.1 Global Ophthalmology Drugs & Devices Sales Market Share by Manufacturers (2017-2022)
2.2 Global Ophthalmology Drugs & Devices Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Ophthalmology Drugs & Devices Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Ophthalmology Drugs & Devices Manufacturing Sites, Area Served, Product Type
2.5 Ophthalmology Drugs & Devices Market Competitive Situation and Trends
2.5.1 Ophthalmology Drugs & Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Ophthalmology Drugs & Devices Players Market Share by Revenue
2.5.3 Global Ophthalmology Drugs & Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Ophthalmology Drugs & Devices Retrospective Market Scenario by Region
3.1 Global Ophthalmology Drugs & Devices Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Ophthalmology Drugs & Devices Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Ophthalmology Drugs & Devices Market Facts & Figures by Country
3.3.1 North America Ophthalmology Drugs & Devices Sales by Country
3.3.2 North America Ophthalmology Drugs & Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Ophthalmology Drugs & Devices Market Facts & Figures by Country
3.4.1 Europe Ophthalmology Drugs & Devices Sales by Country
3.4.2 Europe Ophthalmology Drugs & Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Ophthalmology Drugs & Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Ophthalmology Drugs & Devices Sales by Region
3.5.2 Asia Pacific Ophthalmology Drugs & Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Ophthalmology Drugs & Devices Market Facts & Figures by Country
3.6.1 Latin America Ophthalmology Drugs & Devices Sales by Country
3.6.2 Latin America Ophthalmology Drugs & Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Ophthalmology Drugs & Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Ophthalmology Drugs & Devices Sales by Country
3.7.2 Middle East and Africa Ophthalmology Drugs & Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Ophthalmology Drugs & Devices Historic Market Analysis by Type
4.1 Global Ophthalmology Drugs & Devices Sales Market Share by Type (2017-2022)
4.2 Global Ophthalmology Drugs & Devices Revenue Market Share by Type (2017-2022)
4.3 Global Ophthalmology Drugs & Devices Price by Type (2017-2022)
5 Global Ophthalmology Drugs & Devices Historic Market Analysis by Application
5.1 Global Ophthalmology Drugs & Devices Sales Market Share by Application (2017-2022)
5.2 Global Ophthalmology Drugs & Devices Revenue Market Share by Application (2017-2022)
5.3 Global Ophthalmology Drugs & Devices Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Abbott Ophthalmology Drugs & Devices Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Alcon
6.2.1 Alcon Corporation Information
6.2.2 Alcon Description and Business Overview
6.2.3 Alcon Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Alcon Ophthalmology Drugs & Devices Product Portfolio
6.2.5 Alcon Recent Developments/Updates
6.3 Allergan
6.3.1 Allergan Corporation Information
6.3.2 Allergan Description and Business Overview
6.3.3 Allergan Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Allergan Ophthalmology Drugs & Devices Product Portfolio
6.3.5 Allergan Recent Developments/Updates
6.4 Bausch & Lomb
6.4.1 Bausch & Lomb Corporation Information
6.4.2 Bausch & Lomb Description and Business Overview
6.4.3 Bausch & Lomb Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Bausch & Lomb Ophthalmology Drugs & Devices Product Portfolio
6.4.5 Bausch & Lomb Recent Developments/Updates
6.5 Carl Zeiss Meditec
6.5.1 Carl Zeiss Meditec Corporation Information
6.5.2 Carl Zeiss Meditec Description and Business Overview
6.5.3 Carl Zeiss Meditec Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Carl Zeiss Meditec Ophthalmology Drugs & Devices Product Portfolio
6.5.5 Carl Zeiss Meditec Recent Developments/Updates
6.6 Ellex
6.6.1 Ellex Corporation Information
6.6.2 Ellex Description and Business Overview
6.6.3 Ellex Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Ellex Ophthalmology Drugs & Devices Product Portfolio
6.6.5 Ellex Recent Developments/Updates
6.7 Essilor
6.6.1 Essilor Corporation Information
6.6.2 Essilor Description and Business Overview
6.6.3 Essilor Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Essilor Ophthalmology Drugs & Devices Product Portfolio
6.7.5 Essilor Recent Developments/Updates
6.8 Hoya
6.8.1 Hoya Corporation Information
6.8.2 Hoya Description and Business Overview
6.8.3 Hoya Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Hoya Ophthalmology Drugs & Devices Product Portfolio
6.8.5 Hoya Recent Developments/Updates
6.9 Iridex
6.9.1 Iridex Corporation Information
6.9.2 Iridex Description and Business Overview
6.9.3 Iridex Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Iridex Ophthalmology Drugs & Devices Product Portfolio
6.9.5 Iridex Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Corporation Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Johnson & Johnson Ophthalmology Drugs & Devices Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
6.11 Merck & Co.
6.11.1 Merck & Co. Corporation Information
6.11.2 Merck & Co. Ophthalmology Drugs & Devices Description and Business Overview
6.11.3 Merck & Co. Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Merck & Co. Ophthalmology Drugs & Devices Product Portfolio
6.11.5 Merck & Co. Recent Developments/Updates
6.12 Nidek Co.
6.12.1 Nidek Co. Corporation Information
6.12.2 Nidek Co. Ophthalmology Drugs & Devices Description and Business Overview
6.12.3 Nidek Co. Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.12.4 Nidek Co. Ophthalmology Drugs & Devices Product Portfolio
6.12.5 Nidek Co. Recent Developments/Updates
6.13 Santen Pharmaceutical
6.13.1 Santen Pharmaceutical Corporation Information
6.13.2 Santen Pharmaceutical Ophthalmology Drugs & Devices Description and Business Overview
6.13.3 Santen Pharmaceutical Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Santen Pharmaceutical Ophthalmology Drugs & Devices Product Portfolio
6.13.5 Santen Pharmaceutical Recent Developments/Updates
6.14 Novartis
6.14.1 Novartis Corporation Information
6.14.2 Novartis Ophthalmology Drugs & Devices Description and Business Overview
6.14.3 Novartis Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Novartis Ophthalmology Drugs & Devices Product Portfolio
6.14.5 Novartis Recent Developments/Updates
6.15 Pfizer
6.15.1 Pfizer Corporation Information
6.15.2 Pfizer Ophthalmology Drugs & Devices Description and Business Overview
6.15.3 Pfizer Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Pfizer Ophthalmology Drugs & Devices Product Portfolio
6.15.5 Pfizer Recent Developments/Updates
6.16 Roche Holding
6.16.1 Roche Holding Corporation Information
6.16.2 Roche Holding Ophthalmology Drugs & Devices Description and Business Overview
6.16.3 Roche Holding Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.16.4 Roche Holding Ophthalmology Drugs & Devices Product Portfolio
6.16.5 Roche Holding Recent Developments/Updates
6.17 Staar Surgical
6.17.1 Staar Surgical Corporation Information
6.17.2 Staar Surgical Ophthalmology Drugs & Devices Description and Business Overview
6.17.3 Staar Surgical Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.17.4 Staar Surgical Ophthalmology Drugs & Devices Product Portfolio
6.17.5 Staar Surgical Recent Developments/Updates
6.18 Topcon
6.18.1 Topcon Corporation Information
6.18.2 Topcon Ophthalmology Drugs & Devices Description and Business Overview
6.18.3 Topcon Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.18.4 Topcon Ophthalmology Drugs & Devices Product Portfolio
6.18.5 Topcon Recent Developments/Updates
6.19 Ziemer Ophthalmic Systems
6.19.1 Ziemer Ophthalmic Systems Corporation Information
6.19.2 Ziemer Ophthalmic Systems Ophthalmology Drugs & Devices Description and Business Overview
6.19.3 Ziemer Ophthalmic Systems Ophthalmology Drugs & Devices Sales, Revenue and Gross Margin (2017-2022)
6.19.4 Ziemer Ophthalmic Systems Ophthalmology Drugs & Devices Product Portfolio
6.19.5 Ziemer Ophthalmic Systems Recent Developments/Updates
7 Ophthalmology Drugs & Devices Manufacturing Cost Analysis
7.1 Ophthalmology Drugs & Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Ophthalmology Drugs & Devices
7.4 Ophthalmology Drugs & Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Ophthalmology Drugs & Devices Distributors List
8.3 Ophthalmology Drugs & Devices Customers
9 Ophthalmology Drugs & Devices Market Dynamics
9.1 Ophthalmology Drugs & Devices Industry Trends
9.2 Ophthalmology Drugs & Devices Market Drivers
9.3 Ophthalmology Drugs & Devices Market Challenges
9.4 Ophthalmology Drugs & Devices Market Restraints
10 Global Market Forecast
10.1 Ophthalmology Drugs & Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Ophthalmology Drugs & Devices by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Ophthalmology Drugs & Devices by Type (2023-2028)
10.2 Ophthalmology Drugs & Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Ophthalmology Drugs & Devices by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Ophthalmology Drugs & Devices by Application (2023-2028)
10.3 Ophthalmology Drugs & Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Ophthalmology Drugs & Devices by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Ophthalmology Drugs & Devices by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Ophthalmology Drugs & Devices Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million)
Table 2. Global Ophthalmology Drugs & Devices Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million)
Table 3. Global Ophthalmology Drugs & Devices Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Ophthalmology Drugs & Devices Market Competitive Situation by Manufacturers in 2021
Table 5. Global Ophthalmology Drugs & Devices Sales (K Units) of Key Manufacturers (2017-2022)
Table 6. Global Ophthalmology Drugs & Devices Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Ophthalmology Drugs & Devices Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Ophthalmology Drugs & Devices Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Ophthalmology Drugs & Devices Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Ophthalmology Drugs & Devices Manufacturing Sites and Area Served
Table 11. Manufacturers Ophthalmology Drugs & Devices Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Ophthalmology Drugs & Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ophthalmology Drugs & Devices as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Ophthalmology Drugs & Devices Sales by Region (2017-2022) & (K Units)
Table 16. Global Ophthalmology Drugs & Devices Sales Market Share by Region (2017-2022)
Table 17. Global Ophthalmology Drugs & Devices Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Ophthalmology Drugs & Devices Revenue Market Share by Region (2017-2022)
Table 19. North America Ophthalmology Drugs & Devices Sales by Country (2017-2022) & (K Units)
Table 20. North America Ophthalmology Drugs & Devices Sales Market Share by Country (2017-2022)
Table 21. North America Ophthalmology Drugs & Devices Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Ophthalmology Drugs & Devices Revenue Market Share by Country (2017-2022)
Table 23. Europe Ophthalmology Drugs & Devices Sales by Country (2017-2022) & (K Units)
Table 24. Europe Ophthalmology Drugs & Devices Sales Market Share by Country (2017-2022)
Table 25. Europe Ophthalmology Drugs & Devices Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Ophthalmology Drugs & Devices Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Ophthalmology Drugs & Devices Sales by Region (2017-2022) & (K Units)
Table 28. Asia Pacific Ophthalmology Drugs & Devices Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Ophthalmology Drugs & Devices Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Ophthalmology Drugs & Devices Revenue Market Share by Region (2017-2022)
Table 31. Latin America Ophthalmology Drugs & Devices Sales by Country (2017-2022) & (K Units)
Table 32. Latin America Ophthalmology Drugs & Devices Sales Market Share by Country (2017-2022)
Table 33. Latin America Ophthalmology Drugs & Devices Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Ophthalmology Drugs & Devices Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Ophthalmology Drugs & Devices Sales by Country (2017-2022) & (K Units)
Table 36. Middle East and Africa Ophthalmology Drugs & Devices Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Ophthalmology Drugs & Devices Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Ophthalmology Drugs & Devices Revenue Market Share by Country (2017-2022)
Table 39. Global Ophthalmology Drugs & Devices Sales by Type (2017-2022) & (K Units)
Table 40. Global Ophthalmology Drugs & Devices Sales Market Share by Type (2017-2022)
Table 41. Global Ophthalmology Drugs & Devices Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Ophthalmology Drugs & Devices Revenue Share by Type (2017-2022)
Table 43. Global Ophthalmology Drugs & Devices Price by Type (2017-2022) & (USD/Unit)
Table 44. Global Ophthalmology Drugs & Devices Sales (K Units) by Application (2017-2022)
Table 45. Global Ophthalmology Drugs & Devices Sales Market Share by Application (2017-2022)
Table 46. Global Ophthalmology Drugs & Devices Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Ophthalmology Drugs & Devices Revenue Share by Application (2017-2022)
Table 48. Global Ophthalmology Drugs & Devices Price by Application (2017-2022) & (USD/Unit)
Table 49. Abbott Corporation Information
Table 50. Abbott Description and Business Overview
Table 51. Abbott Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 52. Abbott Ophthalmology Drugs & Devices Product
Table 53. Abbott Recent Developments/Updates
Table 54. Alcon Corporation Information
Table 55. Alcon Description and Business Overview
Table 56. Alcon Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 57. Alcon Ophthalmology Drugs & Devices Product
Table 58. Alcon Recent Developments/Updates
Table 59. Allergan Corporation Information
Table 60. Allergan Description and Business Overview
Table 61. Allergan Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 62. Allergan Ophthalmology Drugs & Devices Product
Table 63. Allergan Recent Developments/Updates
Table 64. Bausch & Lomb Corporation Information
Table 65. Bausch & Lomb Description and Business Overview
Table 66. Bausch & Lomb Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 67. Bausch & Lomb Ophthalmology Drugs & Devices Product
Table 68. Bausch & Lomb Recent Developments/Updates
Table 69. Carl Zeiss Meditec Corporation Information
Table 70. Carl Zeiss Meditec Description and Business Overview
Table 71. Carl Zeiss Meditec Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 72. Carl Zeiss Meditec Ophthalmology Drugs & Devices Product
Table 73. Carl Zeiss Meditec Recent Developments/Updates
Table 74. Ellex Corporation Information
Table 75. Ellex Description and Business Overview
Table 76. Ellex Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. Ellex Ophthalmology Drugs & Devices Product
Table 78. Ellex Recent Developments/Updates
Table 79. Essilor Corporation Information
Table 80. Essilor Description and Business Overview
Table 81. Essilor Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Essilor Ophthalmology Drugs & Devices Product
Table 83. Essilor Recent Developments/Updates
Table 84. Hoya Corporation Information
Table 85. Hoya Description and Business Overview
Table 86. Hoya Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Hoya Ophthalmology Drugs & Devices Product
Table 88. Hoya Recent Developments/Updates
Table 89. Iridex Corporation Information
Table 90. Iridex Description and Business Overview
Table 91. Iridex Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. Iridex Ophthalmology Drugs & Devices Product
Table 93. Iridex Recent Developments/Updates
Table 94. Johnson & Johnson Corporation Information
Table 95. Johnson & Johnson Description and Business Overview
Table 96. Johnson & Johnson Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Johnson & Johnson Ophthalmology Drugs & Devices Product
Table 98. Johnson & Johnson Recent Developments/Updates
Table 99. Merck & Co. Corporation Information
Table 100. Merck & Co. Description and Business Overview
Table 101. Merck & Co. Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Merck & Co. Ophthalmology Drugs & Devices Product
Table 103. Merck & Co. Recent Developments/Updates
Table 104. Nidek Co. Corporation Information
Table 105. Nidek Co. Description and Business Overview
Table 106. Nidek Co. Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 107. Nidek Co. Ophthalmology Drugs & Devices Product
Table 108. Nidek Co. Recent Developments/Updates
Table 109. Santen Pharmaceutical Corporation Information
Table 110. Santen Pharmaceutical Description and Business Overview
Table 111. Santen Pharmaceutical Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 112. Santen Pharmaceutical Ophthalmology Drugs & Devices Product
Table 113. Santen Pharmaceutical Recent Developments/Updates
Table 114. Novartis Corporation Information
Table 115. Novartis Description and Business Overview
Table 116. Novartis Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 117. Novartis Ophthalmology Drugs & Devices Product
Table 118. Novartis Recent Developments/Updates
Table 119. Pfizer Corporation Information
Table 120. Pfizer Description and Business Overview
Table 121. Pfizer Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 122. Pfizer Ophthalmology Drugs & Devices Product
Table 123. Pfizer Recent Developments/Updates
Table 124. Roche Holding Corporation Information
Table 125. Roche Holding Description and Business Overview
Table 126. Roche Holding Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 127. Roche Holding Ophthalmology Drugs & Devices Product
Table 128. Roche Holding Recent Developments/Updates
Table 129. Staar Surgical Corporation Information
Table 130. Staar Surgical Description and Business Overview
Table 131. Staar Surgical Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 132. Staar Surgical Ophthalmology Drugs & Devices Product
Table 133. Staar Surgical Recent Developments/Updates
Table 134. Topcon Corporation Information
Table 135. Topcon Description and Business Overview
Table 136. Topcon Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 137. Topcon Ophthalmology Drugs & Devices Product
Table 138. Topcon Recent Developments/Updates
Table 139. Ziemer Ophthalmic Systems Corporation Information
Table 140. Ziemer Ophthalmic Systems Description and Business Overview
Table 141. Ziemer Ophthalmic Systems Ophthalmology Drugs & Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 142. Ziemer Ophthalmic Systems Ophthalmology Drugs & Devices Product
Table 143. Ziemer Ophthalmic Systems Recent Developments/Updates
Table 144. Production Base and Market Concentration Rate of Raw Material
Table 145. Key Suppliers of Raw Materials
Table 146. Ophthalmology Drugs & Devices Distributors List
Table 147. Ophthalmology Drugs & Devices Customers List
Table 148. Ophthalmology Drugs & Devices Market Trends
Table 149. Ophthalmology Drugs & Devices Market Drivers
Table 150. Ophthalmology Drugs & Devices Market Challenges
Table 151. Ophthalmology Drugs & Devices Market Restraints
Table 152. Global Ophthalmology Drugs & Devices Sales Forecast by Type (2023-2028) & (K Units)
Table 153. Global Ophthalmology Drugs & Devices Sales Market Share Forecast by Type (2023-2028)
Table 154. Global Ophthalmology Drugs & Devices Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 155. Global Ophthalmology Drugs & Devices Revenue Market Share Forecast by Type (2023-2028)
Table 156. Global Ophthalmology Drugs & Devices Sales Forecast by Application (2023-2028) & (K Units)
Table 157. Global Ophthalmology Drugs & Devices Sales Market Share Forecast by Application (2023-2028)
Table 158. Global Ophthalmology Drugs & Devices Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 159. Global Ophthalmology Drugs & Devices Revenue Market Share Forecast by Application (2023-2028)
Table 160. Global Ophthalmology Drugs & Devices Sales Forecast by Region (2023-2028) & (K Units)
Table 161. Global Ophthalmology Drugs & Devices Sales Market Share Forecast by Region (2023-2028)
Table 162. Global Ophthalmology Drugs & Devices Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 163. Global Ophthalmology Drugs & Devices Revenue Market Share Forecast by Region (2023-2028)
Table 164. Research Programs/Design for This Report
Table 165. Key Data Information from Secondary Sources
Table 166. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Ophthalmology Drugs & Devices
Figure 2. Global Ophthalmology Drugs & Devices Market Share by Type in 2021 & 2028
Figure 3. Diagnostic and Monitoring Devices Product Picture
Figure 4. Surgical Devices Product Picture
Figure 5. Vision Care Product Product Picture
Figure 6. Ophthalmology Drugs Product Picture
Figure 7. Global Ophthalmology Drugs & Devices Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Specialty Clinics
Figure 10. Ambulatory Surgical Centers (ASCs)
Figure 11. Global Ophthalmology Drugs & Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Ophthalmology Drugs & Devices Market Size (2017-2028) & (US$ Million)
Figure 13. Global Ophthalmology Drugs & Devices Sales (2017-2028) & (K Units)
Figure 14. Ophthalmology Drugs & Devices Sales Share by Manufacturers in 2021
Figure 15. Global Ophthalmology Drugs & Devices Revenue Share by Manufacturers in 2021
Figure 16. The Global 5 and 10 Largest Ophthalmology Drugs & Devices Players: Market Share by Revenue in 2021
Figure 17. Ophthalmology Drugs & Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 18. Global Ophthalmology Drugs & Devices Sales Market Share by Region (2017-2022)
Figure 19. Global Ophthalmology Drugs & Devices Sales Market Share by Region in 2021
Figure 20. Global Ophthalmology Drugs & Devices Revenue Market Share by Region (2017-2022)
Figure 21. Global Ophthalmology Drugs & Devices Revenue Market Share by Region in 2021
Figure 22. U.S. Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Canada Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. Germany Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. France Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. U.K. Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Italy Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Russia Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. China Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. Japan Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. South Korea Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. India Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Australia Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Taiwan Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Indonesia Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Thailand Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Malaysia Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Philippines Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Vietnam Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Mexico Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Brazil Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Argentina Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. Turkey Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Saudi Arabia Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 45. U.A.E Ophthalmology Drugs & Devices Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 46. Sales Market Share of Ophthalmology Drugs & Devices by Type (2017-2022)
Figure 47. Manufacturing Cost Structure of Ophthalmology Drugs & Devices
Figure 48. Manufacturing Process Analysis of Ophthalmology Drugs & Devices
Figure 49. Ophthalmology Drugs & Devices Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott Alcon Allergan Bausch & Lomb Carl Zeiss Meditec Ellex Essilor Hoya Iridex Johnson & Johnson Merck & Co. Nidek Co. Santen Pharmaceutical Novartis Pfizer Roche Holding Staar Surgical Topcon Ziemer Ophthalmic Systems